Form 4 for MRNA Moderna
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001127602-22-007704 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-02 | 2022-03-01 | MRNA | Andres Juan | See remarks | S - Sale+OE | $152.53 | -6,365 | 9,069 | -41% | -$970.9K |
| D | 2022-03-02 | 2022-02-28 | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | +14.5K | 15.4K | +1,488% | $0 |
| D | 2022-03-02 | 2022-02-28 | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | -14.5K | 14.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | S | D | 6,365 | $152.53 | 9,069 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-28 | M | A | 14,462 | $0.00 | 15,434 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-02-28 | M | D | 14,462 | $0.00 | 14,462 | D | $0.00 · — to — | 14,462 Common Stock | (F3) 50% of the shares subject to this restricted stock unit award vested on February 28, 2022 with the remainder vesting in eight (8) equal quarterly installments thereafter. |